| Multicenter evaluation of breast cancer patients’ satisfaction and experience with oncology telemedicine visits during the COVID-19 pandemic A Bizot, M Karimi, E Rassy, PE Heudel, C Levy, L Vanlemmens, C Uzan, ... British journal of cancer 125 (11), 1486-1493, 2021 | 49 | 2021 |
| New cancer cases at the time of SARS-Cov2 pandemic and related public health policies: a persistent and concerning decrease long after the end of the national lockdown E Kempf, G Lamé, R Layese, S Priou, G Chatellier, H Chaieb, ... European Journal of Cancer 150, 260-267, 2021 | 42 | 2021 |
| High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated with chemotherapy for solid cancers R Palich, M Veyri, A Vozy, S Marot, J Gligorov, MA Benderra, P Maingon, ... Annals of Oncology 32 (10), 1294-1295, 2021 | 38 | 2021 |
| Percutaneous image-guided electrochemotherapy of spine metastases: initial experience FH Cornelis, M Ben Ammar, M Nouri-Neuville, L Matton, MA Benderra, ... CardioVascular and Interventional Radiology 42, 1806-1809, 2019 | 28 | 2019 |
| Standard of care of carcinomas on cancer of unknown primary site in 2016 MA Benderra, M Ilié, P Hofman, C Massard Bulletin du Cancer 103 (7-8), 697-705, 2016 | 15 | 2016 |
| Clinical characteristics, care trajectories and mortality rate of SARS-CoV-2 infected cancer patients: a multicenter cohort study MA Benderra, A Aparicio, J Leblanc, D Wassermann, E Kempf, G Galula, ... Cancers 13 (19), 4749, 2021 | 14 | 2021 |
| The prognostic value of eight comorbidity indices in older patients with cancer: the ELCAPA cohort study F Canoui-Poitrine, L Segaux, MA Benderra, F About, C Tournigand, ... Cancers 14 (9), 2236, 2022 | 13 | 2022 |
| Acquired EGFR mutation as the potential resistance driver to crizotinib in a MET-mutated tumor MA Benderra, S Aspeslagh, S Postel-Vinay, L Bigot, T De Baere, Y Loriot, ... Journal of Thoracic Oncology 11 (2), e21-e23, 2016 | 12 | 2016 |
| Effect of lockdown on digestive system cancer care amongst older patients during the first wave of COVID-19: The CADIGCOVAGE multicentre cohort study T Aparicio, R Layese, F Hemery, C Tournigand, E Paillaud, N De Angelis, ... Digestive and Liver Disease 54 (1), 10-18, 2022 | 9 | 2022 |
| Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program D Bello Roufai, A Goncalves, T De La Motte Rouge, S Akla, C Blonz, ... Oncogene 42 (23), 1951-1956, 2023 | 6 | 2023 |
| 189O A phase II study of patritumab deruxtecan (HER3-DXd), in patients (pts) with advanced breast cancer (ABC), with biomarker analysis to characterize response to therapy … B Pistilli, N Ibrahimi, M Lacroix-Triki, V D'Hondt, C Vicier, JS Frenel, ... ESMO Open 8 (1), 2023 | 5 | 2023 |
| Reliable predictions of forest ecosystem functioning require flawless climate forcings M Jourdan, C François, N Delpierre, NM St-Paul, E Dufrêne Agricultural and Forest Meteorology 311, 108703, 2021 | 5 | 2021 |
| Pazopanib in advanced or metastatic synovial sarcoma: the Gustave Roussy experience M Sroussi, S De Percin, AM Grecea, MA Benderra, M Velev, S Akla, ... Annals of Oncology 29, viii589-viii590, 2018 | 3 | 2018 |
| Management of enzalutamide, a new hormonal therapy P Beuzeboc, MA Benderra, T de La Motte Rouge Bulletin du Cancer 101 (1), 107-112, 2014 | 3 | 2014 |
| The 10-month mortality rate among older patients treated for digestive system cancer during the first wave of the COVID-19 pandemic: The CADIGCOVAGE multicentre cohort study T Aparicio, R Layese, F Hemery, C Tournigand, E Paillaud, N De Angelis, ... Journal of Geriatric Oncology 14 (2), 101443, 2023 | 2 | 2023 |
| Immune-related generalised oedema–A new category of adverse events with immune checkpoint inhibitors M Velev, B Baroudjian, R Pruvost, E De Martin, A Laparra, S Babai, ... European Journal of Cancer 179, 28-47, 2023 | 2 | 2023 |
| Neglected giant benign phyllode tumor of the breast MA Benderra, C Ferrier, D Buob, J Gligorov, K Kerrou European Journal of Nuclear Medicine and Molecular Imaging 49 (11), 3954-3955, 2022 | 2 | 2022 |
| DNA damage repair gene germline profiling for metastatic prostate cancer patients of different ancestries B Abdi, N Basset, E Perrot, MA Benderra, A Khalil, S Oudard, P Blanchet, ... The Prostate 82 (12), 1196-1201, 2022 | 2 | 2022 |
| Quels biomarqueurs d’avenir? Le point de vue des internes en oncologie ā l’issue du congrčs de l’ESMO 2016 M Auvray, MA Benderra, M Bretagne, S Faouzi, L Lebellec, L Majhoubi, ... Bulletin du Cancer 104 (9), 744-751, 2017 | 2 | 2017 |
| Abstract P2-13-26: Trastuzumab deruxtecan in previously treated HER2-positive metastatic or unresectable breast cancer (BC): First real-life data from the cohort temporary … T Petit, N Hajjaji, EC Antoine, MA Benderra, M Gozy, C Foa, JL Mouysset, ... Cancer Research 82 (4_Supplement), P2-13-26-P2-13-26, 2022 | 1 | 2022 |
